Yahoo
NasdaqCM - Delayed Quote USD

enGene Therapeutics Inc. (ENGN)

1.4500 -0.0800 (-5.23%)
At close: November 2 at 4:00:02 PM EST
Trade ENGN on Coinbase

Earnings Trends

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue --
Earnings -32.5M
Profit Margin 0.00%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

-30M
-20M
-10M
0
0.0%

Revenue Estimate

Currency in USD
Current Qtr. (Oct 2026)
Next Qtr. (Jan 2027)
Current Year (2026)
Next Year (2027)
No. of Analysts
8 4 8 7
Avg. Estimate
-- -- -- 5.6M
Low Estimate
-- -- -- --
High Estimate
-- -- -- 14.67M
Year Ago Sales
-- -- -- --
Sales Growth (year/est)
0.00% 0.00% 0.00% 0.00%

Earnings Estimate

GAAP
Normalized
Currency in USD
Current Qtr. (Oct 2026)
Next Qtr. (Jan 2027)
Current Year (2026)
Next Year (2027)
No. of Analysts
8 3 8 7
Avg. Estimate
-0.46 -0.34 -1.81 -1.51
Low Estimate
-0.55 -0.39 -1.89 -1.98
High Estimate
-0.37 -0.3 -1.71 -1.03
Year Ago EPS
-0.73 -0.44 -2.29 -1.81

Earnings History

GAAP
Normalized
Currency in USD
10/31/2025
1/31/2026
4/30/2026
7/31/2026
EPS Est.
-0.58 -0.57 -0.47 -0.43
EPS Actual
-0.73 -0.44 -0.43 -0.47
Difference
-0.15 0.13 0.04 -0.04
Surprise %
-26.22% 23.31% 8.60% -9.95%

EPS Trend

GAAP
Normalized
Currency in USD
Current Qtr. (Oct 2026)
Next Qtr. (Jan 2027)
Current Year (2026)
Next Year (2027)
Current Estimate
-0.46 -0.34 -1.81 -1.51
7 Days Ago
-0.46 -0.34 -1.81 -1.51
30 Days Ago
-0.46 -0.34 -1.81 -1.45
60 Days Ago
-0.41 -0.31 -1.73 -1.4
90 Days Ago
-0.41 -0.31 -1.73 -1.4

EPS Revisions

GAAP
Normalized
Currency in USD
Current Qtr. (Oct 2026)
Next Qtr. (Jan 2027)
Current Year (2026)
Next Year (2027)
Up Last 7 Days
2 -- 2 3
Up Last 30 Days
2 -- 2 3
Down Last 7 Days
5 3 6 4
Down Last 30 Days
5 3 6 4

Growth Estimates

Symbol Current Qtr. Next Qtr. Current Year Next Year
ENGN
37.19% 22.73% 20.98% 16.54%
S&P 500
26.99% 26.80% 32.87% 16.85%

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: